{"slideshow_credits": null, "snippet": "Some analysts believe Valeant remains better positioned to take over Salix, given potential shareholder votes, an F.D.A. review and financial issues.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://www.nytimes.com/2015/03/13/business/dealbook/uncertainty-weighs-on-endos-higher-bid-for-salix-pharmaceuticals.html", "lead_paragraph": "Some analysts believe Valeant remains better positioned to take over Salix, given potential shareholder votes, an F.D.A. review and financial issues.", "headline": {"main": "Uncertainty Weighs on Endo\u2019s Higher Bid for Salix Pharmaceuticals", "content_kicker": "News Analysis", "kicker": "News Analysis"}, "_id": "5501c82038f0d8082e60cece", "word_count": "699", "multimedia": [], "pub_date": "2015-03-13T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Endo International PLC", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Paulson & Co", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}